Erratum
Erratum: The preliminary study on the effect of PSEN1 on the proliferation and invasion of breast cancer cells
Translational Breast Cancer Research
2026;
7:
40
.
(30 July 2026)
Editorial Commentary
MRI-guided de-escalation in HER2-positive early breast cancer: precision progress with necessary prudence
Translational Breast Cancer Research
2026;
7:
39
.
(30 July 2026)
Editorial Commentary
Cancer as an evolutionary reversal—time for a paradigm shift
Translational Breast Cancer Research
2026;
7:
38
.
(30 July 2026)
Editorial Commentary
Targeted axillary dissection versus sentinel lymph node biopsy after neoadjuvant chemotherapy: are we underestimating the clinical significance of staging accuracy?
Translational Breast Cancer Research
2026;
7:
37
.
(30 July 2026)
Editorial Commentary
Minimal-access nipple-sparing mastectomy: current evidence, limitations, and future evaluation
Translational Breast Cancer Research
2026;
7:
36
.
(30 July 2026)
Case Report
Development of acute myeloid leukemia (AML) in two breast cancer patients undergoing treatment with long-term palbociclib: a dual case report
Translational Breast Cancer Research
2026;
7:
35
.
(30 July 2026)
Review Article
OneMark™ breast localisation: integrating diagnosis and surgical guidance—a narrative review
Translational Breast Cancer Research
2026;
7:
34
.
(30 July 2026)
Review Article
Axillary surgery in the cyclin-dependent kinase 4/6 inhibitors era: no time to move backward
Translational Breast Cancer Research
2026;
7:
33
.
(30 July 2026)
Review Article
Role of circulating tumor cell clusters in breast cancer
Translational Breast Cancer Research
2026;
7:
32
.
(30 July 2026)
Review Article
Current perspectives on circulating tumor DNA in breast cancer: a narrative review
Translational Breast Cancer Research
2026;
7:
31
.
(30 July 2026)
Review Article
Evidence and gaps in tumor-agnostic therapies for breast cancer: a narrative review
Translational Breast Cancer Research
2026;
7:
30
.
(30 July 2026)
Review Article
ESR1 fusions in breast cancer: functions, mechanisms and therapeutic opportunities
Translational Breast Cancer Research
2026;
7:
29
.
(30 July 2026)
Review Article
Therapeutics and toxicity management of human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: a narrative review
Translational Breast Cancer Research
2026;
7:
28
.
(30 July 2026)
Review Article
Progress of Trop-2-targeted antibody-drug conjugates in HER-2-negative breast cancer: a mini-review
Translational Breast Cancer Research
2026;
7:
27
.
(30 July 2026)
Original Article
Effectiveness of different non-surgical scar reduction methods in post-operative scars: a systematic review and meta-analysis
Translational Breast Cancer Research
2026;
7:
26
.
(30 July 2026)
Original Article
Risk factors associated with cardiac events among breast cancer survivors at a Saudi tertiary cancer center: a retrospective cohort study
Translational Breast Cancer Research
2026;
7:
25
.
(30 July 2026)
Original Article
Complications, patient satisfaction, clinical outcomes, and aesthetic outcomes of nipple-sparing vs. skin-sparing mastectomies: a systematic review and meta-analysis
Translational Breast Cancer Research
2026;
7:
24
.
(30 July 2026)
Original Article
Comparative outcomes of conventional versus endoscopic-assisted surgery for breast phyllodes tumors: a single center retrospective cohort study
Translational Breast Cancer Research
2026;
7:
23
.
(30 July 2026)
